SCHEMBL2861899

SCHEMBL2861899

O=C(O)c1cc2c(-c3cccc(F)c3)n[nH]c2cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K4 P45985 9/20 0.58
MAPK1 P28482 2/20 0.49
MAPK6 Q16659 2/20 0.49
MAPKAPK3 Q16644 1/20 0.47
GSK3A P49840 1/20 0.44
GSK3B P49841 1/20 0.44
DHODH Q02127 2/20 0.44
PTPN2 P17706 2/20 0.43
PTPN1 P18031 2/20 0.43
PTPN6 P29350 2/20 0.43
DUSP3 P51452 2/20 0.43
PTPN11 Q06124 2/20 0.43
PTPN22 Q9Y2R2 2/20 0.43
PTPRC P08575 1/20 0.43
PTPN9 P43378 1/20 0.43
MAP2K7 O14733 2/20 0.43
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
DCLRE1B Q9H816 1/20 0.41
KMO O15229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2857674 0.88 MAP2K4 (0.60) MAP2K4MAPK1MAPK6MAPKAPK3GSK3A
SCHEMBL2864745 0.87 MAP2K4 (0.58) MAP2K4MAPK1MAPK6MAPKAPK3GSK3A
SCHEMBL2864251 0.83 MAP2K4 (0.54) MAP2K4MAPK1MAPK6MAPKAPK3GSK3A
SCHEMBL2866807 0.82 DYRK1A (0.52) MAP2K4GSK3AGSK3BMAP2K7
SCHEMBL2860783 0.81 MAP2K4 (0.52) MAP2K4MAPK1MAPK6MAPKAPK3GSK3A
SCHEMBL4334601 0.80 MAP4K4 (0.50) MAP2K4MAPK1GSK3AGSK3BMAP2K7
SCHEMBL2859867 0.79 MAP2K4 (0.81) MAP2K4MAPK1MAPK6MAPKAPK3GSK3A
SCHEMBL2858476 0.79 MAP2K4 (0.68) MAP2K4MAPK1MAPK6MAPKAPK3CSNK2A2
SCHEMBL4332627 0.79 MAPK8 (0.49) MAP2K4MAPK1HSP90AA1HSP90AB1
SCHEMBL2858316 0.77 MAP2K4 (0.52) MAP2K4MAPK1MAPK6MAPKAPK3DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885MAPK1 1/4885MAPK6 24/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAP2K4 53/4885MAPK1 1/4885MAPK6 5/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAP2K4 61/4885MAPK1 1/4885MAPK6 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.